Skip to content
Head to head

Novocure vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: NVCR · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

NVCR -5.0%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
NVCRABT
Snapshot
SectorMedical DevicesMedical Devices
Last price10.71103.00
Change today+0.19%-0.84%
1-year return-6.5%-15.4%
Market cap$1.25B$178.39B
52-week range9.82 – 21.4580.89 – 126.70
Valuation
P/E (TTM)-10.1038.29
P/E percentile, own 5-yr range61st99th
P/B3.573.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-1.223.72
Net profit (TTM)$-142.64M$6.44B
Revenue (TTM)$725.39M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+15.7%+14.5%
Gross margin77.0%56.9%
Operating margin-17.2%13.8%
Net margin-16.8%9.7%
Free cash flow (TTM)$-24.61M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership89.2%81.2%
Insider activity (12mo)31 buy / 19 sell36 buy / 12 sell
Short interest (% of float)11.0%1.1%
Analyst consensus100% buy (3)93% buy / 7% hold (15)
Analyst price target$27 (+149%)$122 (+18%)
StockVane view
StockVane Quant RatingD (32)D (22)
Company
Employees1,605115,000
Founded20001900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.